NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001222

Registered date:01/08/2008

Registry of Japanese Rheumatoid Arthritis Patients on Biologics for Long-term Safety (REAL)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedrheumatoid arthritis
Date of first enrollment2005/05/01
Target sample size2000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeIncidence rate of serious adverse events.
Secondary OutcomeType of serious adverse events, long term prognosis, death rates.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaA patient who has any of the following will be excluded from the study. 1. When a patient is participating in a clinical trial for approval of drugs (i.e., chiken) at the enrollment. 2. When a patient is regarded as inappropriate to join the study based on medical reasons or other rational reasons. 3. When a patient refuses to join the study or withdraw his or her consent. 4. When it is revealed that a patient did not satisfy the inclusion criteria at the enrollment or satisfies one of the exclusion criteria at the enrollment.

Related Information

Contact

public contact
Name Masayoshi Harigai
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan Japan
Telephone 03-5803-4677
E-mail mharigai.mpha@tmd.ac.jp
Affiliation REAL study headquarters Tokyo Medical and Dental University, Department of Pharmacovigilance
scientific contact
Name Masayoshi Harigai
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan Japan
Telephone 03-5803-4677
E-mail mharigai.mpha@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Department of Pharmacovigilance